{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:40:52Z","timestamp":1791499252410,"version":"4.3.4"},"reference-count":55,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.jcyt.2015.03.613","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T06:58:15Z","timestamp":1428735495000},"page":"989-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Selection of adenovirus-specific and Epstein-Barr virus\u2013specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)\u2013compliant conditions"],"prefix":"10.1016","volume":"17","author":[{"given":"Christine","family":"Freim\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Stemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Artwohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lothar","family":"Germeroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Tischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britta","family":"Eiz-Vesper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Knippertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"D\u00f6rrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Schaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Fritsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Geyeregger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.03.613_bib1","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcyt.2015.03.613_bib2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/tid.12022","article-title":"European guidelines for diagnosis and treatment of adenovirus infection in leukemia and stem cell transplantation: summary of ECIL-4 (2011)","volume":"14","author":"Matthes-Martin","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jcyt.2015.03.613_bib3","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1128\/CMR.00052-07","article-title":"Adenoviruses in immunocompromised hosts","volume":"21","author":"Echavarria","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jcyt.2015.03.613_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1182\/blood-2002-07-2152","article-title":"Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease","volume":"102","author":"Lion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib5","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/leu.2010.4","article-title":"Monitoring of adenovirus load in stool by real-time PCR permits early detection of impending invasive infection in patients after allogeneic stem cell transplantation","volume":"24","author":"Lion","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2015.03.613_bib6","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3324\/haematol.11279","article-title":"Disseminated adenovirus infections after allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcome","volume":"92","author":"Robin","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2015.03.613_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1399-3062.2006.00184.x","article-title":"Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir","volume":"9","author":"Symeonidis","year":"2007","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.jcyt.2015.03.613_bib8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.bbmt.2011.09.007","article-title":"Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients","volume":"18","author":"Florescu","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.613_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcv.2010.10.016","article-title":"Eradication of disseminated adenovirus infection in a pediatric hematopoietic stem cell transplantation recipient using the novel antiviral agent CMX001","volume":"50","author":"Paolino","year":"2011","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib10","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib11","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2141.2004.05331.x","article-title":"Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation","volume":"128","author":"Feuchtinger","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib12","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib13","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2015.03.613_bib15","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1038\/mt.2012.130","article-title":"Rapidly Generated Multivirus-specific Cytotoxic T Lymphocytes for the Prophylaxis and Treatment of Viral Infections","volume":"20","author":"Gerdemann","year":"2012","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2015.03.613_bib16","doi-asserted-by":"crossref","first-page":"e59592","DOI":"10.1371\/journal.pone.0059592","article-title":"Short-Term In-Vitro Expansion Improves Monitoring and Allows Affordable Generation of Virus-Specific T-Cells against Several Viruses for a Broad Clinical Application","volume":"8","author":"Geyeregger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2015.03.613_bib17","first-page":"245","article-title":"First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation","volume":"37","author":"Geyeregger","year":"2014","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.jcyt.2015.03.613_bib18","doi-asserted-by":"crossref","first-page":"e109944","DOI":"10.1371\/journal.pone.0109944","article-title":"Human Adenovirus-Specific gamma\/delta and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation","volume":"9","author":"Dorrie","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2015.03.613_bib19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1055\/s-0033-1333749","article-title":"Adoptive T-cell transfer for refractory viral infections with cytomegalovirus, Epstein-Barr virus or adenovirus after allogeneic stem cell transplantation","volume":"225","author":"Feucht","year":"2013","journal-title":"Klin Padiatr"},{"key":"10.1016\/j.jcyt.2015.03.613_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib21","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1200\/JCO.2011.39.8495","article-title":"Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation","volume":"31","author":"Icheva","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12967-014-0336-5","article-title":"Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells","volume":"12","author":"Tischer","year":"2014","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.jcyt.2015.03.613_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/90950","article-title":"Differential regulation of antiviral T-cell immunity results in stable CD8+ but declining CD4+ T-cell memory","volume":"7","author":"Homann","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2015.03.613_bib25","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nri3020","article-title":"Interrogating the repertoire: broadening the scope of peptide-MHC multimer analysis","volume":"11","author":"Davis","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000107416","article-title":"Immunotherapy with antibody-targeted HLA class I complexes: results of in\u00a0vivo tumour cell killing and therapeutic vaccination","volume":"28","author":"Savage","year":"2007","journal-title":"Tumour Biol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00262-009-0778-4","article-title":"Multimer technologies for detection and adoptive transfer of antigen-specific T cells","volume":"59","author":"Casalegno-Garduno","year":"2010","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2015.03.613_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jim.2006.01.006","article-title":"Dextramers: new generation of fluorescent MHC class I\/peptide multimers for visualization of antigen-specific CD8+ T cells","volume":"310","author":"Batard","year":"2006","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jcyt.2015.03.613_bib29","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/intimm\/dxs059","article-title":"Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes","volume":"24","author":"Tischer","year":"2012","journal-title":"Int Immunol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib30","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/nm0602-631","article-title":"Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer","volume":"8","author":"Knabel","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2015.03.613_bib31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jcyt.2014.05.023","article-title":"Clinical-scale isolation of 'minimally manipulated' cytomegalovirus-specific donor lymphocytes for the treatment of refractory cytomegalovirus disease","volume":"16","author":"Odendahl","year":"2014","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.613_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2015.03.613_bib33","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/cid\/cis625","article-title":"Rapid salvage treatment with virus-specific T cells for therapy-resistant disease","volume":"55","author":"Uhlin","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2015.03.613_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1537-2995.2010.02940.x","article-title":"Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation","volume":"51","author":"Schmitt","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2015.03.613_bib35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1182\/blood-2013-12-547349","article-title":"Lowest numbers of primary CD8+ T cells can reconstitute protective immunity upon adoptive immunotherapy","volume":"124","author":"Stemberger","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.virol.2009.10.049","article-title":"Ex\u00a0vivo detection of adenovirus specific CD4+ T-cell responses to HLA-DR-epitopes of the Hexon protein show a contracted specificity of T(HELPER) cells following stem cell transplantation","volume":"397","author":"Serangeli","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.jcyt.2015.03.613_bib37","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1099\/vir.0.019471-0","article-title":"Generation of cytotoxic T-cell lines using overlapping pentadecapeptides derived from conserved regions of the\u00a0adenovirus hexon protein","volume":"91","author":"Zhu","year":"2010","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/1099800402238332","article-title":"Major histocompatibility complex (MHC) tetramer technology: an evaluation","volume":"4","author":"Constantin","year":"2002","journal-title":"Biol Res Nurs"},{"key":"10.1016\/j.jcyt.2015.03.613_bib39","doi-asserted-by":"crossref","first-page":"192ra187","DOI":"10.1126\/scitranslmed.3005958","article-title":"TCR-ligand koff rate correlates with the protective capacity of antigen-specific CD8+ T cells for adoptive transfer","volume":"5","author":"Nauerth","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2015.03.613_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/imr.12133","article-title":"T\u00a0lymphocytes targeting native receptors","volume":"257","author":"Rooney","year":"2014","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jcyt.2015.03.613_bib41","first-page":"410","article-title":"Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry","volume":"3","author":"Eiz-Vesper","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib42","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1128\/JVI.02650-06","article-title":"New adenovirus species found in a patient presenting with gastroenteritis","volume":"81","author":"Jones","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib43","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2004-02-0646","article-title":"Conserved CTL epitopes on the adenovirus hexon protein expand subgroup cross-reactive and subgroup-specific CD8+ T cells","volume":"104","author":"Leen","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib44","first-page":"423","article-title":"HLA-peptide multimer selection of adenovirus-specific T cells for adoptive T-cell therapy","volume":"36","author":"Chakupurakal","year":"2013","journal-title":"J\u00a0Immunother"},{"key":"10.1016\/j.jcyt.2015.03.613_bib45","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3324\/haematol.2010.022947","article-title":"Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection","volume":"95","author":"Zandvliet","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2015.03.613_bib46","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1182\/asheducation-2013.1.342","article-title":"T-cell therapy for viral infections","volume":"2013","author":"Heslop","year":"2013","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jcyt.2015.03.613_bib47","first-page":"595","article-title":"Robust multi-parameter single-platform quantification of myeloid and B-lymphoid CD34 progenitor cells in all clinical CD34 cell sources and in thawed PBSC","volume":"29","author":"Fritsch","year":"2012","journal-title":"Pediatr Hematol Oncol"},{"key":"10.1016\/j.jcyt.2015.03.613_bib48","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00262-005-0098-2","article-title":"A\u00a0new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes","volume":"55","author":"Schaft","year":"2006","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2015.03.613_bib49","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/bmt.2014.86","article-title":"Human AdV-specific T cells: persisting in\u00a0vitro functionality despite lethal irradiation","volume":"49","author":"Geyeregger","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.613_bib50","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3324\/haematol.2013.093690","article-title":"A\u00a0Good Manufacturing Practice procedure to engineer donor virus-specific T cells into potent anti-leukemic effector cells","volume":"99","author":"van Loenen","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2015.03.613_bib51","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/587749","article-title":"Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study","volume":"46","author":"Yao","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jcyt.2015.03.613_bib52","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jim.2013.07.014","article-title":"The abrogation of TCR-independent interactions with human serum ensures a selective capture of therapeutic virus-specific CD8+ T-cells by multimer technology in Adoptive Immunotherapy","volume":"396","author":"Beloki","year":"2013","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jcyt.2015.03.613_bib53","doi-asserted-by":"crossref","first-page":"e35798","DOI":"10.1371\/journal.pone.0035798","article-title":"Novel serial positive enrichment technology enables clinical multiparameter cell sorting","volume":"7","author":"Stemberger","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jcyt.2015.03.613_bib54","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.613_bib55","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.immuni.2009.10.002","article-title":"The quest for CD8+ memory stem cells","volume":"31","author":"Neuenhahn","year":"2009","journal-title":"Immunity"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915006970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915006970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:22:02Z","timestamp":1761430922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324915006970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1465324915006970"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.613","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection of adenovirus-specific and Epstein-Barr virus\u2013specific T cells with major histocompatibility class I streptamers under Good Manufacturing Practice (GMP)\u2013compliant conditions","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.613","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}